CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $180,830 | +60.1% | 21,553 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $112,938 | -3.5% | 21,553 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $116,975 | +48.4% | 21,424 | +32.3% | 0.00% | +100.0% |
| Q3 2019 | $78,850 | -36.6% | 16,191 | -9.8% | 0.00% | -50.0% |
| Q2 2019 | $124,449 | +21.5% | 17,958 | +21.8% | 0.00% | 0.0% |
| Q1 2019 | $102,450 | +3.4% | 14,741 | -13.2% | 0.00% | 0.0% |
| Q4 2018 | $99,122 | -22.6% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $128,146 | -99.9% | 16,973 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $85,713,000 | -17.2% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $103,536,000 | +100420.4% | 16,973 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $103,000 | -56.7% | 14,550 | -56.3% | 0.00% | 0.0% |
| Q3 2017 | $238,000 | +12.8% | 33,287 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $211,000 | – | 33,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |